PC
DMAA

Periscope Capital’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Periscope Capital’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,000
Closed -$525K – 508
2026
Q1 		$525K Hold
50,000
– – 0.06% 218
2025
Q4 		$519K Hold
50,000
– – 0.06% 180
2025
Q3 		$514K Buy
+50,000
New +$513K 0.08% 140

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Periscope Capital's DMAA Position: Q2 2026 in Review

Periscope Capital sold out of Drugs Made In America Acquisition Corp (DMAA) in Q2 2026, closing a stake of 50,000 shares — an estimated $525K sold.

Periscope Capital first reported a position in DMAA in Q3 2025 and held it in 3 quarters. The position peaked at $525K in Q1 2026. 23 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • Periscope Capital reported no remaining Drugs Made In America Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Periscope Capital sold 50,000 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $525K.
  • Periscope Capital first reported a position in Drugs Made In America Acquisition Corp in Q3 2025 and held it in 3 quarters.
  • Periscope Capital's Drugs Made In America Acquisition Corp position peaked at $525K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on Periscope Capital's 13F filing for Q2 2026, filed 11 Aug 2026.